United Capital Financial Advisers, LLC Omeros Corp Transaction History

United Capital Financial Advisers, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 14, 2023	BUY	$2.48 - $5.22 $48,960 - $103,053	19,742 New	19,742 $91,000
Q1 2023 May 15, 2023	BUY	$2.48 - $5.22 $48,960 - $103,053	19,742 New	19,742 $91,000
Q3 2022 Nov 14, 2022	BUY	$3.09 - $7.46 $185 - $447	60 Added 0.06%	104,293 $329,000
Q1 2022 May 16, 2022	BUY	$5.07 - $7.2 $50 - $72	10 Added 0.01%	104,233 $626,000
Q3 2021 Nov 15, 2021	SELL	$13.4 - $16.3 $27,751 - $33,757	-2,071 Reduced 1.95%	104,223 $1.44 Million
Q1 2021 May 14, 2021	BUY	$14.52 - $23.53 $145,069 - $235,088	9,991 Added 10.37%	106,294 $1.89 Million
Q4 2020 Feb 17, 2021	BUY	$10.14 - $15.19 $40,205 - $60,228	3,965 Added 4.29%	96,303 $1.38 Million
Q3 2020 Nov 13, 2020	BUY	$9.57 - $21.32 $9 - $21	1 Added 0.0%	92,338 $933,000
Q1 2020 May 15, 2020	SELL	$9.03 - $19.72 $63,209 - $138,040	-7,000 Reduced 7.05%	92,337 $660,000
Q3 2019 Nov 14, 2019	SELL	$14.55 - $20.56 $20,457 - $28,907	-1,406 Reduced 1.4%	99,337 $1.62 Million
Q2 2019 Aug 13, 2019	BUY	$15.0 - $19.62 $37,125 - $48,559	2,475 Added 2.52%	100,743 $1.58 Million
Q4 2018 Feb 14, 2019	BUY	$10.72 - $16.73 $48,240 - $75,285	4,500 Added 4.8%	98,268 $1.1 Million
Q3 2018 Nov 14, 2018	SELL	$17.73 - $26.69 $184,267 - $277,389	-10,393 Reduced 9.98%	93,768 $2.29 Million
Q2 2018 Aug 14, 2018	SELL	$10.79 - $24.44 $5,783 - $13,099	-536 Reduced 0.51%	104,161 $1.89 Million
Q1 2018 May 15, 2018	BUY	$9.0 - $20.16 $27,225 - $60,984	3,025 Added 2.98%	104,697 $1.17 Million
Q4 2017 Feb 13, 2018	BUY	$13.26 - $22.86 $1.35 Million - $2.32 Million	101,672	101,672 $1.98 Million

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $712M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on United Capital Financial Advisers, LLC with notifications on news.